secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001140361-26-010591
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys amends convertible notes, removes anti-dilution, issues 16.4M warrants at $0.58; board adds director
--------------------------------------------------------------------------------

- Omnibus Amendment removes Share Combination Event Adjustment from $10.5M+ senior secured convertible notes and warrants, effective Dec 31, 2025.
- As consideration, lenders receive 16,378,563 Series D-1 Warrants exercisable at $0.58 per share (Nasdaq minimum price on March 19, 2026).
- Director Joshua Silverman resigned March 17, 2026; no disagreement. Board appointed Kenneth D. Eichenbaum, M.D., effective March 18, 2026.
- Amendment expands Securities Purchase Agreement participation right exclusion to cover Series D-1 Warrants and underlying shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036126010591/0001140361-26-010591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036126010591/ef20068469_form8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-010591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer